The European Medicines Agency said on Tuesday that it is set to decide whether to authorise Johnson & Johnson's single-shot coronavirus vaccine for the 27-nation EU on March 11. "EMA's human medicines committee expected to give its recommendation for Covid-19 vaccine from Janssen (J&J's European subsidiary) on 11 March" at a special meeting, the Amsterdam-based regulator said on Twitter. dk/mjs